A. El-Ouaghlidi

Secretion of incretin hormones (GIP and GLP-1) and incretin effect after oral glucose in first-degree relatives of patients with type 2 diabetes

Michael A. Nauck, A. El-Ouaghlidi, Bartholomäus Gabrys et al. · Regulatory Peptides · 2004 · 137 citations

Medicine, Endocrinology, Internal Medicine +14

The Dipeptidyl Peptidase 4 Inhibitor Vildagliptin Does Not Accentuate Glibenclamide-Induced Hypoglycemia but Reduces Glucose-Induced Glucagon-Like Peptide 1 and Gastric Inhibitory Polypeptide Secretion

A. El-Ouaghlidi, Erika Rehring, Jens J. Holst et al. · The Journal of Clinical Endocrinology & Metabolism · 2007 · 115 citations · Full text

Medicine, Endocrinology, Pharmacology +17

The therapeutic actions of DPP-IV inhibition are not mediated by glucagon-like peptide-1

Michael A. Nauck, A. El-Ouaghlidi · Diabetologia · 2005 · 91 citations · Full text

Life Sciences, Biochemistry, Pharmacology +7

40th EASD Annual Meeting of the European Association for the Study of Diabetes

M. Veitenhansl, K. Stegner, F. X. Hierl et al. · Diabetologia · 2004 · 68 citations · Full text

Medicine, Endocrinology, Diabetology +11

Blood glucose control in healthy subject and patients receiving intravenous glucose infusion or total parenteral nutrition using glucagon-like peptide 1

Michael A. Nauck, Jörg Walberg, Arndt Vethacke et al. · Regulatory Peptides · 2004 · 46 citations

Medicine, Endocrinology, Nutrition +17